Clinical Development and Regulatory Strategies for SC Drug and Device Development

Dr. Theuer will review clinical and regulatory strategies resulting in the approval of pharmaceuticals administered by the subcutaneous route of administration including through the use of devices, including the administration of high concentration and high volume biologic therapies. His talk will emphasize the streamlining of the complexity of approvals over the past several years.